What drugs does MIDWEST MEDCL make?

MIDWEST MEDCL has 3 FDA-approved drugs.

What therapeutic areas does MIDWEST MEDCL focus on?

MIDWEST MEDCL focuses primarily on Oncology and Neurology.

← Back

Data updated: Jun 28, 2026

MIDWEST MEDCL

Generics

Oncology Neurology

MIDWEST MEDCL is a generic drug manufacturer focused on Oncology, Neurology.

2015

Since

Drugs

Trials

New Drugs (2yr)

Modality:

1 Small Molecules

MIDWEST MEDCL's Key Drugs

MIDWEST MEDCL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

MIDWEST MEDCL's Recent FDA Approvals

New NDA/BLA approvals for MIDWEST MEDCL over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

MIDWEST MEDCL's Therapeutic Areas

MIDWEST MEDCL's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Oncology 50%

1 drugs

Neurology 50%

1 drugs

MIDWEST MEDCL's Top Competitors

MIDWEST MEDCL's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

Bristol-Myers Squibb big-pharma

Oncology, Neurology